These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 16798104

  • 1. Effects of carvedilol on M2 receptors and cholinesterase-positive nerves in adriamycin-induced rat failing heart.
    Xu XL, Zang WJ, Lu J, Kang XQ, Li M, Yu XJ.
    Auton Neurosci; 2006 Dec 30; 130(1-2):6-16. PubMed ID: 16798104
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of distribution of cholinergic nerves and M2 receptors between rat atria and ventricles].
    Xu XL, Zang WJ, Kang XQ, Li M, Yu XJ, Chen LN, Luo HL.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug 30; 26(8):1096-100. PubMed ID: 16939892
    [Abstract] [Full Text] [Related]

  • 3. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
    Hanada K, Asari K, Saito M, Kawana J, Mita M, Ogata H.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):194-200. PubMed ID: 18534575
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Carvedilol.
    Frishman WH.
    N Engl J Med; 1998 Dec 10; 339(24):1759-65. PubMed ID: 9845712
    [No Abstract] [Full Text] [Related]

  • 6. Hemodynamic effects of carvedilol infusion and the contribution of the sympathetic nervous system in rats with heart failure.
    Abe Y, Watanabe K, Sato S, Nagai Y, Kamal FA, Wahed MI, Wen J, Narasimman G, Ma M, Suresh P, Takahashi T, Tachikawa H, Kashimura T, Tanabe N, Kodama M, Aizawa Y, Yamaguchi K, Miyazaki M, Kakemi M.
    Pharmacology; 2004 Dec 10; 72(4):213-9. PubMed ID: 15539880
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of low and high doses of carvedilol on restoration of cardiac function and calcium-handling proteins in rat failing heart.
    Sun YL, Hu SJ, Wang LH, Hu Y, Zhou JY.
    Clin Exp Pharmacol Physiol; 2005 Jul 10; 32(7):553-60. PubMed ID: 16026515
    [Abstract] [Full Text] [Related]

  • 10. Myocardial beta-1 adrenoceptor down-regulation in aging and heart failure: implications for beta-blocker use in older adults with heart failure.
    Ahmed A.
    Eur J Heart Fail; 2003 Dec 10; 5(6):709-15. PubMed ID: 14675848
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Carvedilol blockade of alpha1- and beta-adrenoceptor induced inotropic responses in rats with congestive heart failure.
    Qvigstad E, Sjaastad I, Bøkenes J, Schiander I, Solberg L, Sejersted OM, Osnes JB, Skomedal T.
    Eur J Pharmacol; 2005 May 23; 516(1):51-9. PubMed ID: 15916756
    [Abstract] [Full Text] [Related]

  • 13. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
    Hryniewicz K, Androne AS, Hudaihed A, Katz SD.
    Circulation; 2003 Aug 26; 108(8):971-6. PubMed ID: 12912816
    [Abstract] [Full Text] [Related]

  • 14. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M, Sasayama S, Kitabatake A, Toyo-oka T, Handa S, Yokoyama M, Matsuzaki M, Takeshita A, Origasa H, Matsui K, Hosoda S, MUCHA Investigators.
    Am Heart J; 2004 Feb 26; 147(2):324-30. PubMed ID: 14760332
    [Abstract] [Full Text] [Related]

  • 15. Beta blockers improve outcome in patients with heart failure and atrial fibrillation: U.S. carvedilol study.
    Ramaswamy K.
    Card Electrophysiol Rev; 2003 Sep 26; 7(3):229-32. PubMed ID: 14739719
    [Abstract] [Full Text] [Related]

  • 16. Does atrial fibrillation in very elderly patients with chronic systolic heart failure limit the use of carvedilol?
    Cioffi G, De Feo S, Pulignano G, Del Sindaco D, Tarantini L, Stefenelli C, Opasich C.
    Int J Cardiol; 2006 Feb 15; 107(2):220-4. PubMed ID: 16412800
    [Abstract] [Full Text] [Related]

  • 17. Carvedilol: use in chronic heart failure.
    Doughty RN, White HD.
    Expert Rev Cardiovasc Ther; 2007 Jan 15; 5(1):21-31. PubMed ID: 17187454
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Beta-blockers in congestive heart failure: the pharmacology of carvedilol, a vasodilating beta-blocker and antioxidant, and its therapeutic utility in congestive heart failure.
    Feuerstein G, Ruffolo RR.
    Adv Pharmacol; 1998 Jan 15; 42():611-5. PubMed ID: 9327976
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.